
Sign up to save your podcasts
Or
2024 was weight-loss injections such as Ozempic and WeGovy went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
4.7
99 ratings
2024 was weight-loss injections such as Ozempic and WeGovy went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
266 Listeners
827 Listeners
139 Listeners
292 Listeners
160 Listeners
651 Listeners
981 Listeners
171 Listeners
246 Listeners
17 Listeners
40 Listeners
4 Listeners
30 Listeners
71 Listeners
3,385 Listeners
201 Listeners
3,124 Listeners
90 Listeners
54 Listeners
976 Listeners
1,128 Listeners
58 Listeners
13 Listeners
48 Listeners
406 Listeners
38 Listeners
472 Listeners
1 Listeners
4 Listeners
100 Listeners
5 Listeners
7 Listeners
156 Listeners